The consolidated entity anticipates completing the Cantrixil toxicology evaluation by the end of 2015.This information will enable regulators, such as the FDA and clinical investigators to assess the drug’s safety, ascribe a starting dose in humans, and establish AE/SAE monitoring criteria in humans.
Ninja -C what you read at the top of page 6 is the wish list for the coming year. The above line is how it stands at present.
Cheers
- Forums
- ASX - By Stock
- Ann Coming
The consolidated entity anticipates completing the Cantrixil...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)